Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to provide written consent to participate
- People of any biological sex or gender identity
- People aged 18 or older (for the healthy volunteer group) or aged 55 or older (for the group with age-related macular degeneration, known as AMD)
- People who understand German or English well enough to follow study information and procedures
- Healthy volunteers: People who have no deposits in the eye called drusen larger than 63 micrometres, and no subretinal drusenoid deposits, in either eye
- Early AMD group: People whose study eye has drusen larger than 63 micrometres but smaller than 125 micrometres, with no pigmentary (colour or tissue) changes in the eye
- Intermediate AMD group: People whose study eye has drusen larger than 125 micrometres and/or pigmentary changes in the eye
Who may not be able to join:
- People with claustrophobia that would affect their ability to tolerate dark-adaptation procedures used in the study
- People with a known allergy or sensitivity to indocyanine green (a dye used in eye imaging), sodium iodide, or iodine, or who have an overactive thyroid (hyperthyroidism)
- People who are known to be pregnant
- People whose study eye has had any eye surgery other than cataract surgery, YAG capsulotomy, or laser retinopexy
- People whose study eye has an eye disease that the investigators believe could affect visual function testing
- People with medical conditions or planned operations that could interfere with completing follow-up visits
- People who are unable to follow study procedures or who do not have sufficient language skills in German or English
- People who are unable to provide informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 228 287 15505
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rod-Intercept Time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.